| 1. |
Mochizuki M, Smith J R, Takase H, et al. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis[J]. Br J Ophthalmol, 2019, 103(10): 1418-1422. DOI: 10.1136/bjophthalmol-2018-313356.
|
| 2. |
Jamilloux Y, Kodjikian L, Broussolle C, et al. Sarcoidosis and uveitis[J]. Autoimmun Rev, 2014, 13(8): 840-849. DOI: 10.1016/j.autrev.2014.04.001.
|
| 3. |
Acharya NR, Browne EN, Rao N, et al. Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients[J]. Ophthalmology, 2018, 125(1): 119-126. DOI: 10.1016/j.ophtha.2017.07.006.
|
| 4. |
Jones NP. Sarcoidosis and uveitis[J]. Ophthalmol Clin North Am, 2002, 15(3): 319-326. DOI: 10.1016/s0896-1549(02)00021-4.
|
| 5. |
Menezo V, Lobo A, Yeo TK, et al. Ocular features in neurosarcoidosis[J]. Ocul Immunol Inflamm, 2009, 17(3): 170-178. DOI: 10.1080/09273940802687812.
|
| 6. |
Ma SP, Rogers SL, Hall AJ, et al. Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis[J]. Am J Ophthalmol, 2019, 198: 30-36. DOI: 10.1016/j.ajo.2018.09.013.
|
| 7. |
杨培增, 谭涵丹, 叶子, 等. 结节病性葡萄膜炎的临床特征分析[J]. 中华眼科杂志, 2023, 59(3): 196-201. DOI: 10.3760/cma.j.cn112142-20220801-00375.Yang BZ, Tan HD, Ye Z, et al. Analysis on the clinical features of sarcoid uveitis[J]. Chin J Ophthalmol, 2023, 59(3): 196-201. DOI: 10.3760/cma.j.cn112142-20220801-00375.
|
| 8. |
Tugal-Tutkun I. Systemic vasculitis and the eye[J]. Curr Opin Rheumatol, 2017, 29(1): 24-32. DOI: 10.1097/BOR.0000000000000345.
|
| 9. |
肖骏, 杨波, 尹金植, 等. 结节病性脉络膜肉芽肿一例[J]. 中华眼底病杂志, 2011, 27(1): 94-95. DOI: 10.3760/cma.j.issn.1005-1015.2011.01.029.Xiao J, Yang B, Yin JZ, et al. A case of sarcoidosis choroidal granuloma[J]. Chin J Ocul Fundus Dis, 2011, 27(1): 94-95. DOI: 10.3760/cma.j.issn.1005-1015.2011.01.029.
|
| 10. |
Wang F, Guo D, Liu Z, et al. Neurosarcoidosis: clinical characteristics, diagnosis, and treatment in eight Chinese patients[J]. Neurol Sci, 2018, 39(10): 1725-1733. DOI: 10.1007/s10072-018-3491-2.
|
| 11. |
Fritz D, van de Beek D, Brouwer MC. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis[J]. BMC Neurol, 2016, 16(1): 220. DOI: 10.1186/s12883-016-0741-x.
|
| 12. |
Krumholz A, Stern BJ. Neurologic manifestations of sarcoidosis[J]. Handb Clin Neurol, 2014, 119: 305-333. DOI: 10.1016/B978-0-7020-4086-3.00021-7.
|
| 13. |
吴悦, 刘耀童, 王祎, 等. 以全葡萄膜炎及面瘫首诊的眼结节病1例[J]. 大连医科大学学报, 2023, 45(3): 283-285. DOI: 10.11724/jdmu.2023.03.20.Wu Y, Liu YT, Wang Y, et al. A case of ocular nodular disease with the initial diagnosis of total uveitis and facial palsy[J]. Journal of Dalian Medical University, 2023, 45(3): 283-285. DOI: 10.11724/jdmu.2023.03.20.
|
| 14. |
Linke M, Pham HT, Katholnig K, et al. Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression[J]. Nat Immunol, 2017, 18(3): 293-302. DOI: 10.1038/ni.3655.
|
| 15. |
曹绪胜, 王红, 彭晓燕. 经组织病理学检查确诊的结节病葡萄膜炎的临床特征[J]. 中华医学杂志, 2020, 100(32): 2498-2502. DOI: 10.3760/cma.j.cn112137-20200426-01323.Cao XS, Wang H, Peng XY. Clinical characteristics of patients with biopsy-proven sarcoid uveitis[J]. Natl Med J China, 2020, 100(32): 2498-2502. DOI: 10.3760/cma.j.cn112137-20200426-01323.
|
| 16. |
Llanos O, Hamzeh N. Sarcoidosis[J]. Med Clin North Am, 2019, 103(3): 527-534. DOI: 10.1016/j.mcna.2018.12.011.
|
| 17. |
中华医学会呼吸病学分会间质性肺疾病学组, 中国医师协会呼吸医师分会间质性肺疾病工作委员会. 中国肺结节病诊断和治疗专家共识[J]. 中华结核和呼吸杂志, 2019, 42(9): 685-693. DOI: 10.3760/cma.j.issn.1001-0939.2019.09.007.Interstitial Lung Disease Group, Chinese Thoracic Society, Chinese Medical Association Interstitial Lung Disease Working Committee, Chinese Association of Chest Physicians, Chinese Medical Doctor Association. Chinese expert consensus on the diagnosis and treatment of pulmonary sarcoidosis[J]. Chin J Tuberc and Respir Dis, 2019, 42(9): 685-693. DOI: 10.3760/cma.j.issn.1001-0939.2019.09.007.
|
| 18. |
Ungprasert P, Tooley AA, Crowson CS, et al. Clinical characteristics of ocular sarcoidosis: a population-based study 1976-2013[J]. Ocul Immunol Inflamm, 2019, 27(3): 389-395. DOI: 10.1080/09273948.2017.1386791.
|
